Temocapril

Temocapril is a dipeptide. Temocapril is a prodrug-type angiotensin-I converting enzyme (ACE) inhibitor not approved for use in the United States, but is approved in Japan and South Korea. Temocapril can also be used in hemodialysis patients without risk of serious accumulation. It is grouped under the following drug class(es): ACE Inhibitors. Its therapeutic use is listed as cardiovascular. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Temocaprilum, 2-[(2S)-6-[[(1S)-1-Ethoxycarbonyl-3-phenyl-propyl]amino]-5-oxo-2-thiophen-2-yl-1 and 4-thiazepan-4-yl]acetic acid. Its PubChem CID is 443874.

CAS No 111902-57-9
Molecular Formula C23H28N2O5S2
Molecular Weight 476.6 g/mol
Synonyms 2-[(2S,6R)-6-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-5-oxo-2-thiophen-2-yl-1,4-thiazepan-4-yl]acetic acid

Frequently Asked Questions